Examkin

Question

Difficulty: Very hardBias and Confounding in Research

A retrospective cohort study investigates the association between a newly approved hypnotic medication and the incidence of next-day motor vehicle accidents (MVAs) among adults diagnosed with insomnia. The overall crude incidence rate ratio (IRR) for MVAs in patients taking the new medication compared to those not taking any sleep medication is 1.65 (95% CI: 1.45-1.85, p < 0.01).

To evaluate potential third variables, the researchers conduct separate stratified analyses for patient age and concurrent use of diphenhydramine.

Stratification by Age:
- Age > 65 years: IRR = 1.10 (95% CI: 0.90-1.30)
- Age ≤ 65 years: IRR = 1.08 (95% CI: 0.85-1.28)

Stratification by concurrent diphenhydramine use:
- Concurrent use: IRR = 3.10 (95% CI: 2.45-3.80)
- No concurrent use: IRR = 1.12 (95% CI: 0.92-1.35)

Which of the following is the most appropriate next step for analyzing and reporting these study results?

  1. A
    Report the overall crude incidence rate ratio to represent the average population risk
  2. B
    Adjust for both covariates using multivariable regression to produce a single pooled estimate
  3. Adjust for age, and present the incidence rate ratio separately for patients with and without concurrent diphenhydramine useAnswer
  4. D
    Adjust for concurrent diphenhydramine use, and present the incidence rate ratio separately for the two age groups
  5. E
    Present four separate incidence rate ratios representing all combinations of age and diphenhydramine use to account for dual effect modification

Answer

Adjust for age, and present the incidence rate ratio separately for patients with and without concurrent diphenhydramine use
The correct approach requires identifying the distinct roles of age and diphenhydramine use. When a crude estimate changes significantly upon stratification, but the stratum-specific estimates are similar to each other (IRRs 1.10 and 1.08 versus crude 1.65), the variable (age) is a confounder. Confounders are nuisance variables that should be controlled for using techniques like multivariable adjustment. Conversely, when stratum-specific estimates are significantly different from one another (IRRs 3.10 versus 1.12), the variable (diphenhydramine use) is an effect modifier. Effect modification reflects a true biological interaction that must be explicitly reported by presenting the results separately for each stratum. Therefore, the data must be adjusted for age and stratified by diphenhydramine use.

Step-by-Step Solution

1
Analyze the stratification by age to determine its epidemiological role.
The age stratum-specific IRRs (1.10 and 1.08) are similar to each other but significantly differ from the crude IRR (1.65).
This pattern defines a confounder. The crude association was falsely elevated because age is related to both the exposure and the outcome.
2
Analyze the stratification by concurrent diphenhydramine use.
The diphenhydramine stratum-specific IRRs (3.10 and 1.12) are markedly different from one another.
This pattern defines an effect modifier. The biological effect of the new medication on MVA risk is synergistic with concurrent diphenhydramine use.
3
Determine the correct reporting strategy for both variables.
Age must be adjusted for, while diphenhydramine use must be stratified.
Confounding is a nuisance variable that distorts the truth and should be removed via statistical adjustment. Effect modification is a natural phenomenon that should be highlighted by presenting stratified results.

Key Concept

In epidemiological studies, confounders distort the true association and should be adjusted for, whereas effect modifiers indicate biological interaction and require stratified reporting.
Rate this question

Topics

Bias and Confounding in Research

More questions from this topic